Positive Press Coverage Somewhat Unlikely to Impact Balchem (BCPC) Share Price
Headlines about Balchem (NASDAQ:BCPC) have trended positive this week, according to Accern. The research group rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Balchem earned a coverage optimism score of 0.37 on Accern’s scale. Accern also assigned media stories about the basic materials company an impact score of 46.4071847623363 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Balchem (NASDAQ:BCPC) opened at $73.56 on Thursday. The company has a market cap of $2,321.27, a P/E ratio of 36.96 and a beta of 1.04. The company has a quick ratio of 1.49, a current ratio of 2.16 and a debt-to-equity ratio of 0.35. Balchem has a 12-month low of $70.23 and a 12-month high of $89.50.
The company also recently announced an annual dividend, which was paid on Friday, January 19th. Stockholders of record on Wednesday, December 27th were given a $0.42 dividend. The ex-dividend date was Tuesday, December 26th. This is a boost from Balchem’s previous annual dividend of $0.38. This represents a dividend yield of 0.5%. Balchem’s payout ratio is presently 21.11%.
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.